GD3 in cellular ageing and apoptosis

Experimental Gerontology

Volumn 37, Issue 10-11, 2002, Pages 1273-1282

  Malisan, Florence ^a   Testi, Roberto ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; Compartmentalization; GD3; Mitochondria; Shedding; Sialic acid

Indexed keywords

CELL PROTEIN; GANGLIOSIDE GD3; GLYCOSPHINGOLIPID; GANGLIOSIDE; GANGLIOSIDE, GD3; N ACETYLNEURAMINIC ACID;

AGING; ANIMAL CELL; APOPTOSIS; CANCER; CELL AGING; CELL DAMAGE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CONFERENCE PAPER; DEGENERATIVE DISEASE; MAMMAL CELL; MICROORGANISM; MITOCHONDRION; NONHUMAN; PHYSICAL DISEASE BY ANATOMICAL STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENESCENCE; TISSUE; ACETYLATION; ANIMAL; CELL COMPARTMENTALIZATION; MAMMAL; METABOLISM; PHYSIOLOGY; REVIEW;

MAMMALIA;

ACETYLATION; ANIMALS; APOPTOSIS; CELL AGING; CELL COMPARTMENTATION; GANGLIOSIDES; MAMMALS; MITOCHONDRIA; N-ACETYLNEURAMINIC ACID;

EID: 0036814886     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(02)00138-9     Document Type: Conference Paper

References (76)

1. Andersson L.M., Fredman P., Lekman A., Rosengren L., Gisslen M. Increased cerebrospinal fluid ganglioside GD3 concentrations as a marker of microglial activation in HIV type 1 infection. AIDS Res. Hum. Retroviruses. 14:1998;1065-1069.
2. Arora A.S., Jones B.J., Patel T.C., Bronk S.F., Gores G.J. Ceramide induces hepatocyte cell death through disruption of mitochondrial function in the rat. Hepatology. 25:1997;958-963.
3. Bergelson L.D. Serum gangliosides as endogenous immunomodulators. Immunol. Today. 16:1995;483-486.
4. Bhunia A.K., Schwarzmann G., Chatterjee S. GD3 recruits reactive oxygen species to induce cell proliferation and apoptosis in human aortic smooth muscle cells. J. Biol. Chem. 22:2002;22.
5. Bieberich E., Tencomnao T., Kapitonov D., Yu R.K. Effect of N-glycosylation on turnover and subcellular distribution of N-acetylgalactosaminyltransferase I and sialyltransferase II in neuroblastoma cells. J. Neurochem. 74:2000;2359-2364.
6. Birkle S., Gao L., Zeng G., Yu R.K. Down-regulation of GD3 ganglioside and its O-acetylated derivative by stable transfection with antisense vector against GD3-synthase gene expression in hamster melanoma cells: effects on cellular growth, melanogenesis, and dendricity. J. Neurochem. 74:2000;547-554.
7. Brown D.A., London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275:2000;17221-17224.
8. Castro-Palomino J.C., Simon B., Speer O., Leist M., Schmidt R.R. Synthesis of ganglioside GD3 and its comparison with bovine GD3 with regard to oligodendrocyte apoptosis mitochondrial damage. Chemistry. 7:2001;2178-2184.
9. Chammas R., Sonnenburg J.L., Watson N.E., Tai T., Farquhar M.G., Varki N.M., Varki A. De-N-acetyl-gangliosides in humans: unusual sub cellular distribution of a novel tumor antigen. Cancer Res. 59:1999;1337-1346.
10. Cheresh D.A., Reisfeld R.A., Varki A.P. O-acetylation of disialoganglioside GD3 by human melanoma cells creates a unique antigenic determinant. Science. 225:1984;844-846.
11. Colell A., Garcia-Ruiz C., Roman J., Ballesta A., Fernandez-Checa J.C. Ganglioside GD3 enhances apoptosis by suppressing the nuclear factor-kappa B-dependent survival pathway. FASEB J. 15:2001;1068-1070.
12. Crocker P.R., Varki A. Siglecs, sialic acids and innate immunity. Trends Immunol. 22:2001;337-342.
13. De Maria R., Lenti L., Malisan F., d'Agostino F., Tomassini B., Zeuner A., Rippo M.R., Testi R. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science. 277:1997;1652-1655.
14. De Maria R., Rippo M.R., Schuchman E.H., Testi R. Acidic sphingomyelinase (ASM) is necessary for Fas-induced GD3 ganglioside accumulation and efficient apoptosis of lymphoid cells. J. Exp. Med. 187:1998;897-902.
15. Dolo V., Li R., Dillinger M., Flati S., Manela J., Taylor B.J., Pavan A., Ladisch S. Enrichment and localization of ganglioside GD3 and caveolin-1 in shed tumor cell membrane vesicles. Biochim. Biophys. Acta. 1486:2000;265-274.
16. Dyatlovitskaya E.V., Bergelson L.D. Glycosphingolipids and antitumor immunity. Biochim. Biophys. Acta. 907:1987;125-143.
17. Ferbeyre G., Lowe S.W. The price of tumor suppression? Nature. 415:2002;26-27.
18. Ferri K.F., Kroemer G. Organelle-specific initiation of cell death pathways. Nat. Cell Biol. 3:2001;E255-E263.
19. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 408:2000;239-247.
20. Fredman P. Gangliosides associated with primary brain tumors and their expression in cell lines established from these tumors. Prog. Brain Res. 101:1994;225-240.
21. Fredman P., Lekman A. Glycosphingolipids as potential diagnostic markers and/or antigens in neurological disorders. Neurochem. Res. 22:1997;1071-1083.
22. Fuentes R., Allman R., Mason M.D. Ganglioside expression in lung cancer cell lines. Lung Cancer. 18:1997;21-33.
23. Fukumoto S., Mutoh T., Hasegawa T., Miyazaki H., Okada M., Goto G., Furukawa K., Urano T. GD3 synthase gene expression in PC12 cells results in the continuous activation of TrkA and ERK1/2 and enhanced proliferation. J. Biol. Chem. 275:2000;5832-5838.
24. Garcia-Ruiz C., Colell A., Paris R., Fernandez-Checa J.C. Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J. 14:2000;847-858.
25. Ghafourifar P., Schenk U., Klein S.D., Richter C. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J. Biol. Chem. 274:1999;31185-31188.
26. Gocht A., Rutter G., Kniep B. Changed expression of 9-O-acetyl GD3 (CDw60) in benign and atypical proliferative lesions and carcinomas of the human breast. Histochem. Cell Biol. 110:1998;217-229.
27. Gocht A., Gadatsch A., Rutter G., Kniep B. CDw60: an antigen expressed in many normal tissues and in some tumors. Histochem. J. 32:2000;447-456.
28. Hanai N., Dohi T., Nores G.A., Hakomori S. A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. J. Biol. Chem. 263:1988;6296-6301.
29. Heidenheim M., Hansen E.R., Baadsgaard O. CDW60, which identifies the acetylated form of GD3 gangliosides, is strongly expressed in human basal cell carcinoma. Br. J. Dermatol. 133:1995;392-397.
30. Inoki Y., Miura T., Kajimoto T., Kawase M., Kawase Y., Yoshida Y., Tsuji S., Kinouchi T., Endo H., Kagawa Y., Hamamoto T. Ganglioside GD3 and its mimetics induce cytochrome c release from mitochondria. Biochem. Biophys. Res. Commun. 276:2000;1210-1216.
31. Kawai H., Sango K., Mullin K.A., Proia R.L. Embryonic stem cells with a disrupted GD3 synthase gene undergo neuronal differentiation in the absence of b-series gangliosides. J. Biol. Chem. 273:1998;19634-19638.
32. Kawai H., Allende M.L., Wada R., Kono M., Sango K., Deng C., Miyakawa T., Crawley J.N., Werth N., Bierfreund U., Sandhoff K., Proia R.L. Mice expressing only monosialoganglioside GM3 exhibit lethal audiogenic seizures. J. Biol. Chem. 276:2001;6885-6888.
33. Kelm S., Schauer R. Sialic acids in molecular and cellular interactions. Int. Rev. Cytol. 175:1997;137-240.
34. Kirkwood T.B., Austad S.N. Why do we age? Nature. 408:2000;233-238.
35. Kolesnick R.N., Goni F.M., Alonso A. Compartmentalization of ceramide signaling: physical foundations and biological effects. J. Cell Physiol. 184:2000;285-300.
36. Koochekpour S., Merzak A., Pilkington G.J. Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett. 102:1996;209-215.
37. Kristal B.S., Brown A.M. Apoptogenic ganglioside GD3 directly induces the mitochondrial permeability transition. J. Biol. Chem. 274:1999;23169-23175.
38. Kroemer G., Reed J.C. Mitochondrial control of cell death. Nat. Med. 6:2000;513-519.
39. Lekman A., Fredman P. A new procedure for determining ganglioside GD3 a potential glial cell activation marker in cerebrospinal fluid. Neurochem. Int. 33:1998;103-108.
40. Liu H., Kojima N., Kurosawa N., Tsuji S. Regulated expression system for GD3 synthase cDNA and induction of differentiation in Neuro2a cells. Glycobiology. 7:1997;1067-1076.
41. Maccioni H.J., Daniotti J.L., Martina J.A. Organization of ganglioside synthesis in the Golgi apparatus. Biochim. Biophys. Acta. 1437:1999;101-118.
42. Martina J.A., Daniotti J.L., Maccioni H.J. Influence of N-glycosylation and N-glycan trimming on the activity and intracellular traffic of GD3 synthase. J. Biol. Chem. 273:1998;3725-3731.
43. Misasi R., Sorice M., Garofalo T., Griggi T., Giammarioli A.M., D'Ettorre G., Vullo V., Pontieri G.M., Malorni W., Pavan A. Overexpression of lymphocytic GD3 ganglioside and presence of anti-GD3 antibodies in patients with HIV infection. AIDS Res. Hum. Retroviruses. 16:2000;1539-1549.
44. Nakayama J., Fukuda M.N., Hirabayashi Y., Kanamori A., Sasaki K., Nishi T., Fukuda M. Expression cloning of a human GT3 synthase. GD3 and GT3 are synthesized by a single enzyme. J. Biol. Chem. 271:1996;3684-3691.
45. Okada M., Itoh Mi M., Haraguchi M., Okajima T., Inoue M., Oishi H., Matsuda Y., Iwamoto T., Kawano T., Fukumoto S., Miyazaki H., Furukawa K., Aizawa S. b-series Ganglioside deficiency exhibits no definite changes in the neurogenesis and the sensitivity to Fas-mediated apoptosis but impairs regeneration of the lesioned hypoglossal nerve. J. Biol. Chem. 277:2002;1633-1636.
46. Ortaldo J.R., Mason A.T., Longo D.L., Beckwith M., Creekmore S.P., McVicar D.W. T cell activation via the disialoganglioside GD3: analysis of signal transduction. J. Leukoc. Biol. 60:1996;533-539.
47. Pastorino J.G., Tafani M., Rothman R.J., Marcinkeviciute A., Hoek J.B., Farber J.L., Marcineviciute A. Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore. J. Biol. Chem. 274:1999;31734-31739.
48. Prieschl E.E., Baumruker T. Sphingolipids: second messengers, mediators and raft constituents in signaling. Immunol. Today. 21:2000;555-560.
49. Prinetti A., Prioni S., Chigorno V., Karagogeos D., Tettamanti G., Sonnino S. Immunoseparation of sphingolipid-enriched membrane domains enriched in Src family protein tyrosine kinases and in the neuronal adhesion molecule TAG-1 by anti-GD3 ganglioside monoclonal antibody. J. Neurochem. 78:2001;1162-1167.
50. Prokazova N.V., Bergelson L.D. Gangliosides and atherosclerosis. Lipids. 29:1994;1-5.
51. Riboni L., Viani P., Bassi R., Prinetti A., Tettamanti G. The role of sphingolipids in the process of signal transduction. Prog. Lipid Res. 36:1997;153-195.
52. Rippo M.R., Malisan F., Ravagnan L., Tomassini B., Condo' I., Costantini P., Susin S.A., Rufini A., Todaro M., Kroemer G., Testi R. GD3 ganglioside directly targets mitochondria in a bcl-2-controlled fashion. FASEB J. 14:2000;2047-2054.
53. Rizzuto R., Pinton P., Carrington W., Fay F.S., Fogarty K.E., Lifshitz L.M., Tuft R.A., Pozzan T. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science. 280:1998;1763-1766.
54. Schuz-Henninger R., Ullmer E., Prinz C., Decker K. The activity of GD3 synthase modulates the ganglioside pattern in rat liver. Eur. J. Biochem. 185:1989;327-330.
55. Scorrano L., Petronilli V., Di Lisa F., Bernardi P. Commitment to apoptosis by GD3 ganglioside depends on opening of the mitochondrial permeability transition pore. J. Biol. Chem. 274:1999;22581-22585.
56. Shi W.X., Chammas R., Varki A. Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells. J. Biol. Chem. 271:1996;15130-15138.
57. Simon B.D., Malisan F., Testi R., Nicotera P., Leist M. Disialoganglioside GD3 is released by microglia and induces oligodendrocyte apoptosis. Cell Death Differ. 9:2002;758-767.
58. Svennerholm L., Gottfries C.G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J. Neurochem. 62:1994;1039-1047.
59. Svennerholm L., Bostrom K., Helander C.G., Jungbjer B. Membrane lipids in the aging human brain. J. Neurochem. 56:1991;2051-2059.
60. Svennerholm L., Bostrom K., Jungbjer B., Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20-100 years. J. Neurochem. 63:1994;1802-1811.
61. Svennerholm L., Bostrom K., Jungbjer B. Changes in weight and compositions of major membrane components of human brain during the span of adult human life of Swedes. Acta Neuropathol. (Berl). 94:1997;345-352.
62. Trbojevic-Cepe M., Kracun I., Jusic A., Pavlicek I. Gangliosides of human cerebrospinal fluid in various neurologic diseases. J. Neurol. Sci. 105:1991;192-199.
63. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Hee Park S., Thompson T., Karsenty G., Bradley A., Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature. 415:2002;45-53.
64. Varki A. Diversity in the sialic acids. Glycobiology. 2:1992;25-40.
65. Varki A. Sialic acids as ligands in recognition phenomena. FASEB J. 11:1997;248-255.
66. Varki A., Hooshmand F., Diaz S., Varki N.M., Hedrick S.M. Developmental abnormalities in transgenic mice expressing a sialic acid-specific 9-O-acetylesterase. Cell. 65:1991;65-74.
67. Wang H.J., Guay G., Pogan L., Sauve R., Nabi I.R. Calcium regulates the association between mitochondria and a smooth sub domain of the endoplasmic reticulum. J. Cell Biol. 150:2000;1489-1498.
68. Wang X.Q., Sun P., Paller A.S. Inhibition of integrin-linked kinase/protein kinase B/Akt signaling: mechanism for Ganglioside-induced apoptosis. J. Biol. Chem. 27:2001;27.
69. Yamashiro S., Okada M., Haraguchi M., Furukawa K., Lloyd K.O., Shiku H. Expression of alpha 2,8-sialyltransferase (GD3 synthase) gene in human cancer cell lines: high level expression in melanomas and up-regulation in activated T lymphocytes. Glycoconj. J. 12:1995;894-900.
70. Yu R.K., Ledeen R.W., Eng L.F. Ganglioside abnormalities in multiple sclerosis. J. Neurochem. 23:1974;169-174.
71. Zeng G., Li D.D., Gao L., Birkle S., Bieberich E., Tokuda A., Yu R.K. Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression. Biochemistry. 38:1999;8762-8769.
72. Zeng G., Gao L., Birkle S., Yu R.K. Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. Cancer Res. 60:2000;6670-6676.
73. Zeng G., Gao L., Yu R.K. Reduced cell migration, tumor growth and experimental metastasis of rat F-11 cells whose expression of GD3-synthase is suppressed. Int. J. Cancer. 88:2000;53-57.
74. Zhou Q., Hakomori S., Kitamura K., Igarashi Y. GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independent of receptor-receptor interaction. J. Biol. Chem. 269:1994;1959-1965.
75. Zhu Z., Deng H., Fenderson B.A., Nudelman E.D., Tsui Z. Glycosphingolipids of human myometrium and endometrium and their changes during the menstrual cycle, pregnancy and ageing. J. Reprod. Fertil. 88:1990;71-79.
76. Ziche M., Morbidelli L., Alessandri G., Gullino P.M. Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Lab. Invest. 67:1992;711-715.